One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
Subscribe To Our Newsletter & Stay Updated
